The Board also voted at the July meeting to fund the APA Diversity Leadership Fellowship from the American Psychiatric Foundation’s reserves, if the foundation’s board approves, to replace the annual $165,000 grant formerly provided by pharmaceutical manufacturer AstraZeneca. The fellowship, which was funded by the company for 15 years, is a vehicle for getting residents involved in the work of APA through participation in the annual meeting and committees, councils, and other components and preparing them for future leadership roles.